Insider Transactions Reported by 15 Insiders of Mereo BioPharma Group plc

Symbol
MREO on Nasdaq
Location
London

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Mereo BioPharma Group plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rubric Capital Management LP 10%+ Owner $61,076,315 17 Jun 2024
Denise Scots-Knight Chief Executive Officer, Director $833,250 01 Feb 2026
Charles Sermon General Counsel $264,620 01 Feb 2026
Christine Ann Fox Chief Financial Officer $264,620 01 Feb 2026
Alexandra Hughes-Wilson Chief Patient Access and Commercial Planning $155,540 01 Feb 2026
John A. Lewicki Chief Scientific Officer $117,160 01 Feb 2026
Marc J. Yoskowitz Director $55,550 26 Feb 2026
Michael S. Wyzga Director $55,550 26 Feb 2026
Jeremy Bender Director $55,550 26 Feb 2026
Pierre Jacquet Director $55,550 26 Feb 2026
Anders Ekblom Director $55,550 26 Feb 2026
Annalisa Jenkins Director $55,550 26 Feb 2026
Deepika Pakianathan Director $55,550 26 Feb 2026
Daniel Shames Director $55,550 26 Feb 2026
Justin Hunter Roberts Director 01 Jan 2024

Recent Insider Transactions by Companies or Individuals for Mereo BioPharma Group plc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Pierre Jacquet MREO Deferred Restricted Stock Units Award 106,848 106,848 26 Feb 2026 Direct
Pierre Jacquet MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Marc J. Yoskowitz MREO Deferred Restricted Stock Units Award 96,163 96,163 26 Feb 2026 Direct
Marc J. Yoskowitz MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Daniel Shames MREO Deferred Restricted Stock Units Award 96,163 96,163 26 Feb 2026 Direct
Daniel Shames MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Anders Ekblom MREO Deferred Restricted Stock Units Award 133,560 133,560 26 Feb 2026 Direct
Anders Ekblom MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Jeremy Bender MREO Deferred Restricted Stock Units Award 117,533 117,533 26 Feb 2026 Direct
Jeremy Bender MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Deepika Pakianathan MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Annalisa Jenkins MREO Deferred Restricted Stock Units Award 106,848 106,848 26 Feb 2026 Direct
Annalisa Jenkins MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Michael S. Wyzga MREO Share Options (Right to buy) Award 66,000 66,000 26 Feb 2026 Direct
Alexandra Hughes-Wilson MREO Share Options (Right to buy) Award 440,000 195,000 01 Feb 2026 Direct
Christine Ann Fox MREO Share Options (Right to buy) Award 701,000 315,750 01 Feb 2026 Direct
Charles Sermon MREO Share Options (Right to buy) Award 716,000 315,750 01 Feb 2026 Direct
John A. Lewicki MREO Share Options (Right to buy) Award 331,550 145,000 01 Feb 2026 Direct
Denise Scots-Knight MREO Share Options (Right to buy) Award 1,860,000 1,035,000 01 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.